Skip to main content

EPA Reform Bills Considered

If passed, Republican-led efforts to change the US Environmental Protection Agency’s handling of science may never make it past the President’s desk.

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

WIKIMEDIA, DAVE_7Advisors to President Obama this week (March 3) argued in favor of vetoing two bills, backed primarily by Republicans, which are aimed at changing practices at the US Environmental Protection Agency (EPA). One of the bills would require that any actions by the agency be supported by publicly available data, while the other would overhaul its scientific advisory board.

According to a statement about the evidence transparency bill, Obama’s advisors said: “The bill would impose arbitrary, unnecessary, and expensive requirements that would seriously impede the [EPA’s] ability to use science to protect public health and the environment. . . . For example, the data underlying some scientifically-important studies is not made broadly available in order to protect the privacy of test subjects, and modeling that EPA uses for a variety of purposes are not EPA property and therefore cannot be publicly released.”

Bill supporter Dana Rohrabacher (R-CA) said there are ways around privacy issues, ScienceInsider reported: study participants could agree to have their data public, and those who don’t agree could decline to join. “Their specific participation isn’t necessary to have a successful research ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile

Related Topics

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad
Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

bioxcell

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays